glp 1 effects on thyroid The Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care 10 Surprising Facts About GLP-1/GIP

Regular updates of Price Comparisons for REGISTERED providers of Prescription only Medication in the UK

Hypothyroidism slows metabolism and makes weight loss harder, but GLP-1 receptor agonists like semaglutide can still be effective when thyroid hormone is optimized

Lower intake increases deficiency risk

They can be minimised through the use of an appropriate stepwise dosing regimen and careful choice of diet

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was associated with better all-cause survival and recurrence-free survival in patients with obesity or type 2 diabetes